Management
Immediate removal of the bee stinger is the most important principle as it precludes any further venom transfer. Traditional teaching recommended scraping the stinger out to avoid squeezing remaining venom into the tissues; however, involuntary muscle contractions of the gland continue after the stinger detaches, and the venom is quickly exhausted. Thus, immediate removal of the stinger is crucial, though the method of removal is now thought irrelevant.19
The mainstay of therapy for serious reactions is intramuscular (IM) epinephrine. The initial dosing is 0.3 to 0.5 mg (0.3 to 0.5 mL of 1:1000 concentration) in adults, and 0.01 mg/kg in children (maximum 0.3 mg). The injection should be IM and not subcutaneous, as IM dosing provides higher and more consistent and rapid peak blood epinephrine levels.20 Concomitant intravenous (IV) administration of standard antihistamines, often diphenhydramine 1 mg/kg (generally 25-50 mg) and histamine-2 receptor antagonists (typically ranitidine 50 mg) are also recommended. The administration of steroids (methylprednisolone 125 mg IV or prednisone 60 mg orally) is traditionally recommended and thought to help potentiate the effect of other interventional measures.20 Bronchospasm, if present, is treated with nebulized β-agonists (albuterol). Hypotension may develop and requires significant crystalloid infusion—often several liters. If hypotension persists despite adequate fluid replacement, vasopressor therapy is recommended.
If a patient does not respond to initial treatment and cardiovascular (CV) collapse is evident, IV infusion of epinephrine should be initiated. Epinephrine, 100 mcg (0.1 mg) IV, should be given as a 1:100,000 dilution. This can be done by placing epinephrine, 0.1 mg (0.1 mL of the 1:1000 dilution), in 10 mL of normal saline solution and infusing it over 5 to 10 minutes (a rate of 1 to 2 mL/min). If the patient is refractory to the initial bolus, then an epinephrine infusion can be started by placing epinephrine, 1 mg (1.0 mL of the 1:1000 dilution), in 500 mL of 5% dextrose in water or NS and administering at a rate of 1 to 4 mcg per minute (0.5 to 2 mL/min), titrating to effect.20 Antivenins have been studied for treatment, but none are commercially available at this time.21 Patients with anaphylaxis associated with severe signs and symptoms, including any evidence of CV collapse, should be admitted to the hospital for aggressive therapy and monitoring. Persons with mild-to-moderate reactions should be observed for 4 to 6 hours to monitor for late occurring symptoms. Outpatient therapy with antihistamines, oral steroids, and a prescription for an epinephrine auto-injector—including training on proper administration prior to discharge—are strongly recommended.22 Follow-up with an allergist is also indicated in patients with significant reactions, as skin testing and immunotherapy may be beneficial to prevent anaphylaxis during future exposures.
Ants
Fire ant venom is composed of an insoluble alkaloid, and crossreactivity with the venom of other Hymenopteras species does exist. Stings generally result in a papule, which evolves into a sterile pustule. Localized necrosis, scarring, and secondary infection can occur. Systemic reactions with angioedema and urticaria have been documented, which can sometimes lead to fatalities.24
Treatment
Treatment of fire ant stings begin and end with local wound care. If the reaction is systemic, a treatment plan similar to that outlined in the treatment section for bees and wasps is indicated.
Araneae
The order Araneae of the phylum Arthropoda includes over 34,000 species of spiders divided into 105 families. Of those, only half a dozen are medically relevant and only three are commonly encountered in the United States. These include Loxosceles (most notably, the brown recluse spider), Tegeneria (mainly the hobo brown spider) and Latrodectus (includes the black widow spider). True spiders have a worldwide distribution and tend to thrive in heavily populated areas, resulting in many biting episodes per year. Data from the AAPPC’s most recent annual report listed 9,255 single spider-bite exposures in 2012, with one associated death.3